/People

Raju Kucherlapati

Investor

Venture Partner at Catalio Capital Management, LP · Member, BOD at PureTech Health · Board director at KEW Group

Weston, Florida

Writes $100K – $5M checks · typically $1.5M

Find your path to Raju

442 people in our graph can introduce you to Raju.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Chris Peetz to introduce you to Raju

You →Chris · together at Abgenix (2005) →Raju

Ask Jamie Chen to introduce you to Raju

You →Jamie · 9 people · together at PureTech Health →Raju

Ask Sam Okafor to introduce you to Raju

You →Sam · 2 people · together at Brigham and Women's Hospital →Raju

Sign up to find every way you can get introduced to Raju

  • Your email: the people you already email who know Raju
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Raju
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Raju Kucherlapati is a Professor of Genetics at Harvard Medical School. He earned his PhD from the University of Illinois Urbana-Champaign and completed postdoctoral training at Yale University, following degrees earned in India. He was elected to the National Academy of Medicine and served on the Presidential Commission for the Study of Bioethical Issues from 2009 to 2017.

Invests in

Biotech

Board director at KEW Group

Intro paths

→

In turn, Raju can intro founders to KEW Group's investors below.

KEW Group's investors · 1

Experience

  1. Harvard Medical SchoolProfessorcurrent2001 — present
  2. Harvard Medical SchoolProfessorcurrent2001 — present
  3. KEW GroupFounder and member BODcurrent2010 — presentGreater Boston Area
  4. Brigham and Women's HospitalProfessor of Medicinecurrent2001 — present
  5. PureTech HealthMember, BODcurrent2014 — presentBoston, Massachusetts, United States
  6. PureTech HealthMember, BODcurrent2014 — present
  7. PureTech HealthMember, BODcurrent2014 — present
  8. Metamark GeneticsMember, Board of Directors2009 — 2021Cambridge, MA
  9. AVEO PharmaceuticalsMember, Board of Directors2002 — 2021
  10. AACRmember2008 — 2015
  11. Enlight BiosciencesMember BOD2008 — 2010
  12. Harvard Partners Center for Genetics and GenomicsScientific Director2001 — 2008
  13. Millennium PharmaceuticalsMember, Board of Directors1993 — 2008
  14. AbgenixMember, Board of Directors1996 — 2006
  15. Albert Einstein College of MedicineProfessor1989 — 2001
  16. Albert Einstein College of MedicineSaul and Lola Kramer Professor and University Chairman1989 — 2001
  17. University of Illinois College of MedicineProfessor1982 — 1989
  18. Princeton UniversityAssistant Professor1975 — 1982

Skills & more

Cancer99Lifesciences46Molecular Biology91Drug Discovery56Cell Biology43Biotechnology61Clinical Development15Biochemistry43Oncology30Clinical Trials18Technology Transfer13Pharmaceutical Industry18
+4 moreClinical ResearchBioinformaticsGenomicsFDA

Languages English

From Raju's professional profile.

Investments

Board seats

AbgenixAVEO PharmaceuticalsCell GenesysGelesisKEW, Inc.Millennium PharmaceuticalsPureTech Health

Sources: the firm's website · curated public sources.

Colleagues at Catalio Capital Management, LP

Frequently asked questions

Who is Raju Kucherlapati?
Raju Kucherlapati is a Professor of Genetics at Harvard Medical School. He earned his PhD from the University of Illinois Urbana-Champaign and completed postdoctoral training at Yale University, following degrees earned in India. He was elected to the National Academy of Medicine and served on the Presidential Commission for the Study of Bioethical Issues from 2009 to 2017.
Where does Raju Kucherlapati work?
Raju Kucherlapati is Venture Partner at Catalio Capital Management, LP and Board director at KEW Group.
What does Raju Kucherlapati invest in?
Raju Kucherlapati invests in Biotech.
What check size does Raju Kucherlapati write?
Raju Kucherlapati typically writes checks of $100K – $5M.
What boards does Raju Kucherlapati sit on?
Raju Kucherlapati holds tracked board seats at Abgenix, AVEO Pharmaceuticals, Cell Genesys, Gelesis, KEW, Inc., Millennium Pharmaceuticals, PureTech Health.
What companies has Raju Kucherlapati invested in?
Investments tracked here include Chimera Bioengineering.
Where did Raju Kucherlapati go to school?
Raju Kucherlapati studied at Yale University (Fellow, Genetics); University of Illinois Urbana-Champaign (PhD, Genetics).

Founder mafias

Same school

Shared employers